


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:24Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406873" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406873</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmjo</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="pmc-domain-id">1609</journal-id><journal-id journal-id-type="pmc-domain">bmjo</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406873</article-id><article-id pub-id-type="pmcid-ver">PMC12406873.1</article-id><article-id pub-id-type="pmcaid">12406873</article-id><article-id pub-id-type="pmcaiid">12406873</article-id><article-id pub-id-type="pmid">40897497</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2024-094497</article-id><article-id pub-id-type="publisher-id">bmjopen-2024-094497</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Protocol</subject></subj-group><subj-group subj-group-type="heading"><subject>Health Services Research</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1704</subject><subject>1506</subject></subj-group></article-categories><title-group><article-title>Establishing a framework of measurement for use in Long COVID research and practice: protocol for a scoping review involving evidence review and consultation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0331-6919</contrib-id><name name-style="western"><surname>McDuff</surname><given-names initials="K">Kiera</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bh&#233;reur</surname><given-names initials="A">Anne</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Kadakia</surname><given-names initials="Z">Zeal</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Corrales-Medina</surname><given-names initials="VF">Vicente F</given-names></name><xref rid="aff4" ref-type="aff">4</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2427-6277</contrib-id><name name-style="western"><surname>Gross</surname><given-names initials="DP">Douglas P</given-names></name><xref rid="aff5" ref-type="aff">5</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Janaudis-Ferreira</surname><given-names initials="T">Tania</given-names></name><xref rid="aff6" ref-type="aff">6</xref><xref rid="aff7" ref-type="aff">7</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7366-193X</contrib-id><name name-style="western"><surname>Lam</surname><given-names initials="G">Grace</given-names></name><xref rid="aff8" ref-type="aff">8</xref><xref rid="aff9" ref-type="aff">9</xref><xref rid="aff10" ref-type="aff">10</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Naik</surname><given-names initials="H">Hiten</given-names></name><xref rid="aff11" ref-type="aff">11</xref><xref rid="aff12" ref-type="aff">12</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5876-1991</contrib-id><name name-style="western"><surname>Paterson</surname><given-names initials="TSE">Theone S E</given-names></name><xref rid="aff13" ref-type="aff">13</xref><xref rid="aff14" ref-type="aff">14</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1637-4309</contrib-id><name name-style="western"><surname>Sanchez-Ramirez</surname><given-names initials="DC">Diana C</given-names></name><xref rid="aff15" ref-type="aff">15</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Sasseville</surname><given-names initials="M">Maxime</given-names></name><xref rid="aff16" ref-type="aff">16</xref><xref rid="aff17" ref-type="aff">17</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Sekar</surname><given-names initials="A">Anisha</given-names></name><xref rid="aff18" ref-type="aff">18</xref><xref rid="equal-contrib1" ref-type="author-notes">0</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Vohra</surname><given-names initials="S">Sunita</given-names></name><xref rid="aff8" ref-type="aff">8</xref><xref rid="aff19" ref-type="aff">19</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Bayley</surname><given-names initials="M">Mark</given-names></name><xref rid="aff20" ref-type="aff">20</xref><xref rid="aff21" ref-type="aff">21</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Birch</surname><given-names initials="S">Susan</given-names></name><xref rid="aff22" ref-type="aff">22</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0178-8712</contrib-id><name name-style="western"><surname>Busse</surname><given-names initials="JW">Jason W</given-names></name><xref rid="aff23" ref-type="aff">23</xref><xref rid="aff24" ref-type="aff">24</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4161-1572</contrib-id><name name-style="western"><surname>Cameron</surname><given-names initials="JI">Jill I</given-names></name><xref rid="aff25" ref-type="aff">25</xref><xref rid="aff26" ref-type="aff">26</xref><xref rid="aff27" ref-type="aff">27</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Kaup</surname><given-names initials="C">Cara</given-names></name><xref rid="aff28" ref-type="aff">28</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Cheung</surname><given-names initials="A">Angela</given-names></name><xref rid="aff21" ref-type="aff">21</xref><xref rid="aff29" ref-type="aff">29</xref><xref rid="aff30" ref-type="aff">30</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Churchill</surname><given-names initials="K">Katie</given-names></name><xref rid="aff25" ref-type="aff">25</xref><xref rid="aff31" ref-type="aff">31</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8865-1921</contrib-id><name name-style="western"><surname>Edgell</surname><given-names initials="H">Heather</given-names></name><xref rid="aff32" ref-type="aff">32</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Goulding</surname><given-names initials="S">Susie</given-names></name><xref rid="aff33" ref-type="aff">33</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Hamilton</surname><given-names initials="C">Clayon</given-names></name><xref rid="aff34" ref-type="aff">34</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2930-1443</contrib-id><name name-style="western"><surname>Jaglal</surname><given-names initials="S">Susan</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff26" ref-type="aff">26</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Kumar</surname><given-names initials="P">Pawan</given-names></name><xref rid="aff35" ref-type="aff">35</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Levin</surname><given-names initials="A">Adeera</given-names></name><xref rid="aff36" ref-type="aff">36</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Munblit</surname><given-names initials="D">Daniel</given-names></name><xref rid="aff37" ref-type="aff">37</xref><xref rid="aff38" ref-type="aff">38</xref><xref rid="aff39" ref-type="aff">39</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6545-7018</contrib-id><name name-style="western"><surname>Naye</surname><given-names initials="F">Florian</given-names></name><xref rid="aff40" ref-type="aff">40</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>O&#8217;Hara</surname><given-names initials="M">Margaret</given-names></name><xref rid="aff41" ref-type="aff">41</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Plaismond</surname><given-names initials="J">James</given-names></name><xref rid="aff16" ref-type="aff">16</xref><xref rid="aff17" ref-type="aff">17</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Rutledge</surname><given-names initials="M">Mark</given-names></name><xref rid="aff27" ref-type="aff">27</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Supper</surname><given-names initials="JMW">Jean-Marc Wilfried</given-names></name><xref rid="aff16" ref-type="aff">16</xref><xref rid="aff17" ref-type="aff">17</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1681-5170</contrib-id><name name-style="western"><surname>Quinn</surname><given-names initials="K">Kieran</given-names></name><xref rid="aff29" ref-type="aff">29</xref><xref rid="aff42" ref-type="aff">42</xref><xref rid="aff43" ref-type="aff">43</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1198-2292</contrib-id><name name-style="western"><surname>Wasilewski</surname><given-names initials="MB">Marina B</given-names></name><xref rid="aff25" ref-type="aff">25</xref><xref rid="aff26" ref-type="aff">26</xref><xref rid="aff44" ref-type="aff">44</xref><xref rid="equal-contrib2" ref-type="author-notes">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilkins</surname><given-names initials="A">Annette</given-names></name><xref rid="aff45" ref-type="aff">45</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1632-6537</contrib-id><name name-style="western"><surname>O&#8217;Brien</surname><given-names initials="KK">Kelly K</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff26" ref-type="aff">26</xref><xref rid="aff27" ref-type="aff">27</xref><xref rid="aff29" ref-type="aff">29</xref><xref rid="cor2" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>1</label><institution content-type="department">Department of Physical Therapy</institution>, <institution>Temerty Faculty of Medicine, University of Toronto</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Department of Family Medicine and Emergency Medicine</institution>, <institution>Faculty of Medicine, Universit&#233; de Montr&#233;al</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Faculty of Medicine and Health Sciences</institution>, <institution>School of Rehabilitation, Universit&#233; de Sherbrooke</institution>, <addr-line content-type="city">Sherbrooke</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff4"><label>4</label><institution content-type="department">Department of Medicine</institution>, <institution>The Ottawa Hospital</institution>, <addr-line content-type="city">Ottawa</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff5"><label>5</label><institution content-type="department">Department of Physical Therapy</institution>, <institution>Faculty of Rehabilitation Medicine, University of Alberta</institution>, <addr-line content-type="city">Edmonton</addr-line>, <addr-line content-type="state">Alberta</addr-line>, <country>Canada</country></aff><aff id="aff6"><label>6</label><institution content-type="department">School of Physical and Occupational Therapy</institution>, <institution>McGill University</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff7"><label>7</label><institution content-type="department">Respiratory Epidemiology and Clinical Research Unit</institution>, <institution>Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre</institution>, <addr-line content-type="city">Montreal</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff8"><label>8</label><institution content-type="department">Alberta Respiratory Centre</institution>, <institution>University of Alberta</institution>, <addr-line content-type="city">Edmonton</addr-line>, <addr-line content-type="state">Alberta</addr-line>, <country>Canada</country></aff><aff id="aff9"><label>9</label><institution content-type="department">Division of Pulmonary Medicine</institution>, <institution>Department of Medicine, University of Alberta and Alberta Health Services</institution>, <addr-line content-type="city">Edmonton</addr-line>, <addr-line content-type="state">Alberta</addr-line>, <country>Canada</country></aff><aff id="aff10"><label>10</label><institution content-type="department">Women and Children&#8217;s Health Research Institute</institution>, <institution>University of Alberta</institution>, <addr-line content-type="city">Edmonton</addr-line>, <addr-line content-type="state">Alberta</addr-line>, <country>Canada</country></aff><aff id="aff11"><label>11</label><institution content-type="department">Department of Medicine</institution>, <institution>The University of British Columbia</institution>, <addr-line content-type="city">Vancouver</addr-line>, <addr-line content-type="state">British Columbia</addr-line>, <country>Canada</country></aff><aff id="aff12"><label>12</label><institution>Post-COVID-19 Interdisciplinary Clinical Care Network</institution>, <addr-line content-type="city">Vancouver</addr-line>, <addr-line content-type="state">British Columbia</addr-line>, <country>Canada</country></aff><aff id="aff13"><label>13</label><institution content-type="department">Department of Psychology</institution>, <institution>University of Victoria</institution>, <addr-line content-type="city">Victoria</addr-line>, <addr-line content-type="state">British Columbia</addr-line>, <country>Canada</country></aff><aff id="aff14"><label>14</label><institution content-type="department">Rotman Research Institute</institution>, <institution>Baycrest Health Sciences Centre</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff15"><label>15</label><institution content-type="department">Department of Respiratory Therapy</institution>, <institution>University of Manitoba</institution>, <addr-line content-type="city">Winnipeg</addr-line>, <addr-line content-type="state">Manitoba</addr-line>, <country>Canada</country></aff><aff id="aff16"><label>16</label><institution content-type="department">Faculty of Nursing</institution>, <institution>Universit&#233; Laval</institution>, <addr-line content-type="city">Quebec City</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff17"><label>17</label><institution content-type="department">VITAM Research Center on sustainable health</institution>, <institution>Universit&#233; Laval</institution>, <addr-line content-type="city">Quebec City</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff18"><label>18</label><institution>Patient-Led Research Collaborative</institution>, <addr-line content-type="city">Washington</addr-line>, <addr-line content-type="state">District of Columbia</addr-line>, <country>USA</country></aff><aff id="aff19"><label>19</label><institution content-type="department">Department of Pediatrics</institution>, <institution>Faculty of Medicine and Dentistry, University of Alberta</institution>, <addr-line content-type="city">Edmonton</addr-line>, <addr-line content-type="state">Alberta</addr-line>, <country>Canada</country></aff><aff id="aff20"><label>20</label><institution>Toronto Rehabilitation Institute, University Health Network</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff21"><label>21</label><institution content-type="department">Department of Medicine</institution>, <institution>University Health Network</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff22"><label>22</label><institution>PossAbility: ME, Long COVID &amp; Work</institution>, <addr-line content-type="city">N/A</addr-line>, <addr-line content-type="state">N/A</addr-line>, <country>Canada</country></aff><aff id="aff23"><label>23</label><institution content-type="department">Department of Anesthesia</institution>, <institution>McMaster University</institution>, <addr-line content-type="city">Hamilton</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff24"><label>24</label><institution content-type="department">Department of Health Research Methods, Evidence and Impact</institution>, <institution>McMaster University</institution>, <addr-line content-type="city">Hamilton</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff25"><label>25</label><institution content-type="department">Department of Occupational Science and Occupational Therapy</institution>, <institution>University of Toronto</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff26"><label>26</label><institution content-type="department">Rehabilitation Sciences Institute</institution>, <institution>University of Toronto</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff27"><label>27</label><institution content-type="department">Rehabilitation Science Research Network for COVID</institution>, <institution>Temerty Faculty of Medicine, University of Toronto</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff28"><label>28</label><institution>Long COVID Physio</institution>, <addr-line content-type="city">Calgary</addr-line>, <addr-line content-type="state">Alberta</addr-line>, <country>Canada</country></aff><aff id="aff29"><label>29</label><institution content-type="department">Institute of Health Policy, Management and Evaluation</institution>, <institution>Dalla Lana School of Public Health, University of Toronto</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff30"><label>30</label><institution content-type="department">Department of Medicine</institution>, <institution>University of Toronto</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff31"><label>31</label><institution>Bruy&#232;re Health</institution>, <addr-line content-type="city">Ottawa</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff32"><label>32</label><institution content-type="department">Kinesiology and Health Sciences, Faculty of Health</institution>, <institution>York University - Keele Campus</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff33"><label>33</label><institution>COVID Long-Haulers Support Group Canada</institution>, <addr-line content-type="city">Cambridge</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff34"><label>34</label><institution>Provincial Health Services Authority</institution>, <addr-line content-type="city">Vancouver</addr-line>, <addr-line content-type="state">British Columbia</addr-line>, <country>Canada</country></aff><aff id="aff35"><label>35</label><institution>Saskatchewan Centre for Patient-Oriented Research</institution>, <addr-line content-type="city">Saskatoon</addr-line>, <addr-line content-type="state">Saskatchewan</addr-line>, <country>Canada</country></aff><aff id="aff36"><label>36</label><institution content-type="department">Division of Nephrology</institution>, <institution>The University of British Columbia</institution>, <addr-line content-type="city">Vancouver</addr-line>, <addr-line content-type="state">British Columbia</addr-line>, <country>Canada</country></aff><aff id="aff37"><label>37</label><institution content-type="department">Division of Care in Long Term Conditions</institution>, <institution>Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King&#8217;s College London</institution>, <addr-line content-type="city">London</addr-line>, <country>UK</country></aff><aff id="aff38"><label>38</label><institution content-type="department">Department of Paediatrics and Paediatric Infectious Diseases</institution>, <institution>Institute of Child&#8217;s Health, Sechenov University</institution>, <addr-line content-type="city">Moscow</addr-line>, <country>Russia</country></aff><aff id="aff39"><label>39</label><institution>Research and Clinical Center for Neuropsychiatry</institution>, <addr-line content-type="city">Moscow</addr-line>, <country>Russia</country></aff><aff id="aff40"><label>40</label><institution content-type="department">Faculty of Medicine and Health Sciences</institution>, <institution>Universit&#233; de Sherbrooke</institution>, <addr-line content-type="city">Sherbrooke</addr-line>, <addr-line content-type="state">Quebec</addr-line>, <country>Canada</country></aff><aff id="aff41"><label>41</label><institution>Long COVID Support</institution>, <addr-line content-type="city">London</addr-line>, <country>UK</country></aff><aff id="aff42"><label>42</label><institution content-type="department">Temmy Latner Centre for Palliative Care</institution>, <institution>Sinai Health</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff43"><label>43</label><institution content-type="department">Department of Medicine</institution>, <institution>Sinai Health</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff44"><label>44</label><institution content-type="department">St. John&#8217;s Rehab Research Program</institution>, <institution>Sunnybrook Research Institute, Sunnybrook Health Sciences Centre</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff><aff id="aff45"><label>45</label><institution>Realize</institution>, <addr-line content-type="city">Toronto</addr-line>, <addr-line content-type="state">Ontario</addr-line>, <country>Canada</country></aff></contrib-group><author-notes><fn><p>Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></fn><fn fn-type="COI-statement" id="fn4"><p>None declared.</p></fn><corresp id="cor1">Kiera McDuff; <email xlink:href="kiera.mcduff@utoronto.ca">kiera.mcduff@utoronto.ca</email></corresp><corresp id="cor2">Dr Kelly K O&#8217;Brien; <email xlink:href="kelly.obrien@utoronto.ca">kelly.obrien@utoronto.ca</email></corresp><fn fn-type="equal" id="equal-contrib1"><p>ZK, VFC-M, DPG, TJ-F, GL, HN, TSEP, DCS-R, MS and AS contributed equally.</p></fn><fn fn-type="equal" id="equal-contrib2"><p>SV, MB, SB, JWB, JIC, CK, AC, KC, HE, SG, CH, SJ, PK, AL, DM, FN, MO&#8217;H, JP, MR, J-MWS, KQ and MBW contributed equally.</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>9</month><year>2025</year></pub-date><volume>15</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496158</issue-id><elocation-id>e094497</elocation-id><history><date date-type="received"><day>01</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:&#160;<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="bmjopen-15-9.pdf"/><self-uri xlink:title="pdf" xlink:href="bmjopen-15-9.pdf"/><abstract><sec><title> Abstract</title></sec><sec><title>Introduction</title><p>Our aim is to develop a Framework of Measurement for people living with Long COVID and their caregivers for use in Long COVID research and clinical practice. Specifically, we will characterise evidence pertaining to outcome measurement and identify implementation considerations for use of outcome measures among adults and children living with Long COVID and their caregivers.</p></sec><sec><title>Methods and analysis</title><p>We will conduct a scoping study involving: (1) an evidence review and (2) a two-phased consultation, using methodological steps outlined by the Arksey and O&#8217;Malley Framework and Joanna Briggs Institute. We will answer the following question: What is known about outcome measures used to describe, evaluate or predict health outcomes among adults and children living with Long COVID and their caregivers? Evidence review: we will review peer review published and grey literature to identify existing outcome measures and their reported measurement properties with people living with Long COVID and their caregivers. We will search databases including MEDLINE, Embase, CINAHL, PsycINFO and Scopus for articles published since 2020. Two authors will independently review titles and abstracts, followed by full text to select articles that discuss or use outcome measures for Long COVID health outcomes, pertain to adults or children living with Long COVID and/or their caregivers and are based in research or clinical settings. We will extract data including article characteristics, terminology and definition of Long COVID, health outcomes assessed, characteristics of outcome measures, measurement properties and implementation considerations. We will collate and summarise data to establish a preliminary Framework of Measurement. Consultation phase 1: we will conduct an environmental scan involving a cross-sectional web-based questionnaire among individuals with experience using or completing outcome measures for Long COVID, to identify outcome measures not found in the evidence review and explore implementation considerations for outcome measurement in the context of Long COVID. Consultation phase 2: we will conduct focus groups to review the preliminary Framework of Measurement and to highlight implementation considerations for outcome measurement in Long COVID. We will analyse questionnaire and focus group data using descriptive and content analytical approaches. We will refine the Framework of Measurement based on the focus group consultation using community-engaged approaches with the research team.</p></sec><sec><title>Ethics and dissemination</title><p>Protocol approved by the University of Toronto Health Sciences Research Ethics Board (protocol #46503) for the consultation phases of the study. Outcomes will include a Framework of Measurement, to enhance measurement of health outcomes in Long COVID research and clinical practice. Knowledge translation will also occur in the form of publications and presentations.</p></sec></abstract><kwd-group><kwd>Post-Acute COVID-19 Syndrome</kwd><kwd>Patient Reported Outcome Measures</kwd><kwd>Surveys and Questionnaires</kwd><kwd>Caregivers</kwd><kwd>Systematic Review</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000245</institution-id><institution>Michael Smith Health Research BC</institution></institution-wrap></funding-source><award-id>Lotte &amp; John Hecht Memorial Foundation Scholar Awa</award-id></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><award-id>Episodic Disability and Rehabilitation (Kelly K. O</award-id><award-id>Prevention and management of chronic pain (Jason W</award-id><award-id>Tier 1 Canada Research Chair in Musculoskeletal an</award-id></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Long COVID Web - Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>FRN 185352</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>STRENGTHS AND LIMITATIONS OF THIS STUDY</title></caption><list list-type="bullet" list-content="ul"><list-item><p>We will use established scoping review methodology; broad selection criteria involving a range of terminologies, study designs and methodologies; and inclusion of an international consultation phase involving key consultants with interest and experience in measurement in the context of Long COVID.</p></list-item><list-item><p>We will assess the methodological quality of included studies pertaining to the development and assessment of outcome measures used among people living with Long COVID and their caregivers.</p></list-item><list-item><p>This study was conceptualised and developed with an international, multidisciplinary community-engaged team comprised of persons with lived experiences of Long COVID, caregivers, clinicians, researchers and representatives from community organisations and networks with expertise in Long COVID and outcome measurement.</p></list-item><list-item><p>Potential challenges include the variability in terminology and definitions of Long COVID in the literature, which we will address by including multiple terms in our search strategy, iteratively expanding our search to incorporate evolving terms and definitions from the literature, consulting an information specialist to develop our search strategy and clearly operationalising concepts of interest in the study to enhance the rigour of study selection and data extraction.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p> Long COVID is a multisystem and often disabling condition that has affected over 400&#8201;million people worldwide as a consequence of SARS-CoV-2 infection.<xref rid="R1" ref-type="bibr">1</xref><xref rid="R5" ref-type="bibr">5</xref> The term Long COVID was coined early in the COVID-19 pandemic by people who were experiencing long-term symptoms after a SARS-CoV-2 infection and is the term preferred by the patient community, over &#8216;Post COVID-19 condition&#8217; or &#8216;Post-Acute Sequelae of SARS-CoV-2&#8217;, for example.<xref rid="R6" ref-type="bibr">6</xref><xref rid="R11" ref-type="bibr">11</xref> Most prevalence estimates of Long COVID range between 7&#8211;30% of people who survive a SARS-CoV-2 infection.<xref rid="R1" ref-type="bibr">15 12</xref><xref rid="R16" ref-type="bibr">16</xref></p><p>The breadth and potentially fluctuating nature of Long COVID symptoms pose challenges to its diagnosis and management. Long COVID is characterised by multidimensional health challenges, spanning physical, mental, emotional and cognitive health domains.<xref rid="R17" ref-type="bibr"><sup>17 18</sup></xref> Over 200 symptoms of Long COVID have been documented, which poses challenges for identifying appropriate outcome measures to describe the impact of the condition.<xref rid="R17" ref-type="bibr"><sup>17 19</sup></xref> The most common symptoms of Long COVID include fatigue, coughing, difficulty breathing, cognitive impairment and general weakness.<xref rid="R5" ref-type="bibr"><sup>5 20</sup></xref> Postexertional malaise or post-exertional symptom exacerbation is also commonly experienced and is characterised by a worsening or relapse of symptoms and reduction in function following previously tolerated, day-to-day physical, cognitive or emotional exertion.<xref rid="R19" ref-type="bibr">1921</xref><xref rid="R23" ref-type="bibr">23</xref> Long COVID symptoms can pose challenges engaging in work or school<xref rid="R19" ref-type="bibr">1924</xref><xref rid="R27" ref-type="bibr">27</xref> with resultant implications on finances, social roles<xref rid="R28" ref-type="bibr"><sup>28 29</sup></xref> and secondary impacts on mental health,<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> for patients and their families. Symptoms of Long COVID can be constant, progressive or remitting and relapsing over time.<xref rid="R7" ref-type="bibr"><sup>7 17</sup></xref> It is important to identify outcome measures that can accurately and safely capture the diversity of Long COVID symptoms and their potentially fluctuating nature.</p><p>Caregivers, such as a family member or a friend supporting a person living with Long COVID, also face challenges including, but not limited to, burnout; deterioration of their own physical, mental or emotional health; and loss of employment.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> The impact of caregiving for people living with Long COVID may be complicated by the multidimensional, unpredictable and fluctuating nature of symptoms,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> challenges navigating the healthcare system for diverse symptoms and the burden of securing social and financial support for the people they care for.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Caregivers are essential for supporting the health and well-being of people living with Long COVID and the sustainability of healthcare systems.<xref rid="R33" ref-type="bibr"><sup>33 34</sup></xref> Hence, it is necessary to consider caregivers when approaching outcome measurement in the context of Long COVID.</p><sec id="s1-1"><title>Importance of measuring outcomes in Long COVID</title><p>The purpose of measuring health outcomes is to describe, predict and evaluate a patient&#8217;s status, which can help to inform treatment approaches, health services, programmes and models of healthcare delivery.<xref rid="R35" ref-type="bibr">35</xref><xref rid="R38" ref-type="bibr">38</xref> In the absence of a validated biomarker of disease activity,<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> patient-reported outcome measures (PROMs), performance-based outcome measures (PBOMs) and patient-reported experience measures (PREMs) can be helpful for assessment and management for people living with Long COVID.<xref rid="R8" ref-type="bibr"><sup>8 34</sup></xref> Most PROMs are tools that patients can complete independently to provide information about their health status; they may be condition-specific or generic.<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> PBOMs are tests which require patients to perform tasks to provide information about their functional abilities.<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> PREMs can evaluate the accessibility and quality of care received, providing information to guide care for people living with Long COVID.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></p><p>Outcome measures for caregivers of people living with Long COVID are also critical for describing outcomes such as caregiver burden, emotional well-being, physical health and quality of life. PROMs can provide self-reported information of caregiver health status and daily living. PREMs can be used to evaluate the accessibility and quality of care received by caregivers.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> Collectively, PROMs, PBOMs and PREMs help describe health outcomes, guide treatment approaches, predict future events or evaluate changes over time among people living with Long COVID and their caregivers.</p></sec><sec id="s1-2"><title>Advancing measurement in Long COVID</title><p>The Post-COVID Condition Core Outcome Set (PC-COS) Project Steering Committee and the Core Outcome Measures for Long COVID Initiative proposed a core outcome set (COS) for adults and children living with Long COVID and a core outcome measures set (COMS) to assess those outcomes.<xref rid="R42" ref-type="bibr">42</xref><xref rid="R45" ref-type="bibr">45</xref> Using an international Delphi process, authors identified 12 core outcomes for adults and seven for children and young people living with Long COVID.<xref rid="R42" ref-type="bibr"><sup>42 44</sup></xref> Through an additional Delphi process, authors achieved consensus on the use of three outcome measures (time until death, Recovery Scale for COVID-19 and Modified Medical Research Council Dyspnoea Scale) in adults and four outcome measures (Pediatric Quality of Life Inventory (PedsQL) multidimensional Fatigue scale; PedsQL Gastrointestinal Symptom scales; PedsQL Cognitive Functioning Scale; and EuroQol 5 Dimension family) in children and young people living with Long COVID.<xref rid="R44" ref-type="bibr"><sup>44 45</sup></xref> However, new outcome measures for people living with Long COVID have since emerged.<xref rid="R46" ref-type="bibr">46</xref><xref rid="R50" ref-type="bibr">50</xref> Furthermore, the COMS did not include PREMs or PBOMs, nor assess measurement properties (validity, reliability, responsiveness, interpretability) of the measures in the context of Long COVID.<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> Finally, exploration of the implementation considerations for outcome measures, such as utility, feasibility, administrative burden, required equipment and training, language translations, health literacy, scoring considerations and possible risk of negative outcomes in the context of Long COVID, is important to consider in the context of clinical practice and research. There is a need to build on the foundational work on measurement in Long COVID to advance the selection of timely and appropriate outcome measures among people living with Long COVID and their caregivers in clinical practice and research.<xref rid="R42" ref-type="bibr">42</xref><xref rid="R45" ref-type="bibr">45</xref></p><p>Our aim is to develop a Framework of Measurement for adults (&#8805;18 years old), children (&lt;18 years old) and caregivers for use in Long COVID research and clinical practice. Specific objectives are to: (1) characterise evidence pertaining to outcome measurement among people living with Long COVID and their caregivers, including (but not limited to) constructs of interest; outcome measures (and their measurement properties); types of outcome measures (PBOMs, PROMs, PREMs); purposes of measurement (discriminative, predictive, evaluative); target populations (adults, children, caregivers) and contexts (research, clinical practice); and (2) identify implementation considerations for measurement among adults and children living with Long COVID and their caregivers. For all outcome measures that are identified, the corresponding constructs of interest, characteristics, context, population and measurement properties (when known in the context of people living with Long COVID), and implementation considerations will be mapped out in the Framework of Measurement.</p></sec></sec><sec id="s2"><title>Methods and analysis</title><sec id="s2-1"><title>Study design</title><p>We will conduct a scoping study involving (1) an evidence review and (2) a consultation, using methodological steps outlined by Arksey and O&#8217;Malley and the Joanna Briggs Institute (JBI) guidelines.<xref rid="R51" ref-type="bibr"><sup>51 52</sup></xref> We developed our protocol in accordance with the Arksey and O&#8217;Malley methodological framework for scoping studies and JBI guidelines.<xref rid="R52" ref-type="bibr"><sup>52 53</sup></xref> We used guidance on the reporting of scoping reviews including the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols (PRISMA-P) to further inform the protocol.<xref rid="R54" ref-type="bibr"><sup>54</sup></xref> We will report our findings as per the PRISMA Scoping Review Reporting Guidelines.<xref rid="R55" ref-type="bibr"><sup>55 56</sup></xref> The study will occur from 1 September 2023 until estimated completion on 31 August 2026.</p><p>We will conduct an evidence review of peer review published and grey (eg, reports, clinical guidelines, policy statements, etc) literature to identify existing outcome measures and their reported measurement properties when used among people living with Long COVID and their caregivers (steps 1&#8211;5). Next, we will conduct a two-phased international consultation. Part 1 will be an environmental scan involving a cross-sectional web-based questionnaire administered to key consultants (including people with lived experiences with Long COVID and caregivers), to identify outcome measures not found in the literature review and explore implementation considerations for outcome measurement in the context of Long COVID (step 6 &#8211; part 1). Phase 2 will be an international focus group with key consultants to review the findings from the evidence review and environmental scan and to highlight implementation considerations for outcome measurement in Long COVID (step 6 &#8211; part 2). Outcomes from this work will include a Framework of Measurement, which will be adapted into an online menu of options which can be used in Long COVID research and clinical practice (See <xref rid="F1" ref-type="fig">figure 1</xref>).</p><fig position="float" id="F1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><title>Overview of study steps. *Outcome measures (OMs) include patient-reported OMs (PROMs), performance-based OMs (PBOMs) and patient-reported OMs (PREMs). **The target population for the consultation phases will be persons with lived experiences, clinicians, researchers, representatives from community organisations and other individuals with experiences using (administering) or completing (themselves or on behalf of someone else) OMs for Long COVID, who are &gt;18 years old.</title></caption><graphic position="float" orientation="portrait" xlink:href="bmjopen-15-9-g001.jpg"/></fig></sec><sec id="s2-2"><title>Patient and public involvement</title><p>This study is funded by Long COVID Web (LCW), a national network to support and conduct research in Long COVID and was conceived and designed with the involvement of members of the LCW Patient Advisory Council.<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> Funded by the Canadian Institutes of Health Research (Fund #185352), LCW is comprised of over 600 members (people living with Long COVID, caregivers, clinicians and researchers).<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> People living with Long COVID, some of whom are members of the LCW Patient Advisory Council, are members of the study team who provide input regarding processes throughout the research. During the consultation phases (step 6 &#8211; parts 1 and 2), we will engage key consultants through the web-based questionnaire and focus groups to help identify outcome measures for inclusion in the Framework of Measurement and considerations for implementation of outcome measurement. Once the framework is published, we will develop an online menu of options of outcome measures used in Long COVID which will be available on the LCW website. For more details, see <xref rid="SP1" ref-type="supplementary-material">online supplemental file 1</xref> &#8211; Principles of Patient Engagement for Measurement and Assessment Paradigm for Long COVID (MAP LC).</p></sec><sec id="s2-3"><title>Ethics and dissemination</title><p>The protocol received approval from the University of Toronto (U of T) Health Sciences Research Ethics Board (protocol #46503) for the consultation phases of the study.</p><p>We will obtain informed consent from potential consultants who wish to participate in phase 1 (web-based questionnaire) or phase 2 (focus groups) consultations. The first page of the web-based questionnaire will include a letter of information and consent (<xref rid="SP2" ref-type="supplementary-material">online supplemental file 2</xref>: Consultation 1 &#8211; Information Letter and Consent Form). Potential consultants will provide written consent to complete the questionnaire by responding &#8216;yes&#8217; to the following item: &#8216;I agree to participate in this consultation&#8217;. Potential focus group consultants will be asked to provide either written or verbal informed consent prior to participating in the focus group discussion (<xref rid="SP3" ref-type="supplementary-material">online supplemental file 3</xref>: Consultation 2 &#8211; Information Letter and Consent Form).</p><p>The U of T is the primary institution for the study, and the only institution where the data are being collected and stored. This is why the protocol received Research Ethics Board (REB) approval from U of T. We are using snowball sampling (word of mouth) to recruit for the consultation. Through this process, we may recruit some consultants who are from countries other than Canada. However, in the information letter consent forms for both consultation phases (<xref rid="SP2" ref-type="supplementary-material">onlinesupplemental files 2 </xref><xref rid="SP3" ref-type="supplementary-material"> 3</xref>), we outline to potential consultants that U of T is the lead institution of the study, that consultation phases of the study went through REB approval at U of T, and that data will be collected and stored at U of T only. We are not recruiting through any academic institution other than U of T.</p><p>Outcomes will include a Framework of Measurement, to enhance measurement of health outcomes in Long COVID research and clinical practice. Knowledge translation will also occur in the form of publications and presentations.</p></sec><sec id="s2-4"><title>Step 1: identifying the research question</title><p>Our primary research question is: what is known about outcome measures used to describe, evaluate or predict health outcomes cross-sectionally (one point in time) or longitudinally (over time) among adults and children living with Long COVID and their caregivers?</p><p>Our secondary research questions are:</p><list list-type="alpha-lower" list-content="ol"><list-item><p>What <underline>outcome measures</underline> (PROMs; PBOMs; PREMs) are used to measure health outcomes among adults and children living with Long COVID and their caregivers?</p></list-item><list-item><p>What are the <underline>constructs </underline>(health outcomes) measured by these outcome measures?</p></list-item><list-item><p>In what <underline>context </underline>(Long COVID-specific or generic; for specific symptoms or phenotypes; research or clinical practice or both) were these outcome measures used?</p></list-item><list-item><p>For what <underline>population </underline>(adults living with Long COVID; children living with Long COVID; caregivers of people living with Long COVID) were these outcome measures used?</p></list-item><list-item><p>For what <underline>purpose </underline>(to describe, evaluate or predict) are these outcome measures used?</p></list-item><list-item><p>What are the reported <underline>measurement properties</underline> of these outcome measures when used among persons living with Long COVID and caregivers (when assessed)?</p></list-item><list-item><p>What are the <underline>implementation considerations</underline> for using those outcome measures in the context of adults and children living with Long COVID and their caregivers?</p></list-item></list></sec><sec id="s2-5"><title>Step 2: identifying relevant studies</title><p>We will locate published and unpublished evidence by searching electronic databases (peer-reviewed articles), reference lists of eligible studies and grey literature. We use the term Long COVID broadly in our own work to encompass all health consequences following a SARS-CoV-2 infection. However, there are multiple terminologies associated with Long COVID.<xref rid="R6" ref-type="bibr">6</xref><xref rid="R59" ref-type="bibr">810 11 20 58 59</xref> Our search strategy will therefore include articles that use any and/or multiple of those terminologies (see <xref rid="SP4" ref-type="supplementary-material">online supplemental file 4</xref>: Long COVID terminology and definitions).</p><p>We established a preliminary database search with an experienced health research information specialist. We will search databases including MEDLINE, Embase, CINAHL, PsycINFO and Scopus for articles published since 2020, considering the context of Long COVID research and practice. We will adapt and refine the search strategy, including all identified keywords and index terms, for each included database in consultation with the same information specialist (<xref rid="SP5" ref-type="supplementary-material">online supplemental file 5</xref>: Exemplar Search Strategy).<xref rid="R44" ref-type="bibr">4460</xref><xref rid="R64" ref-type="bibr">64</xref> We will screen the reference list of all included sources of evidence for additional articles.</p></sec><sec id="s2-6"><title>Step 3: study selection</title><p>We will upload all identified citations and grey literature into Covidence<xref rid="R65" ref-type="bibr"><sup>65</sup></xref> to facilitate our process of screening for inclusion and removing duplicate citations. Any duplicate citations missed by Covidence and identified by authors will be manually removed.</p><p>Six researchers will screen the first 20 citation titles and abstracts collectively to agree on the applicability of the predetermined study selection criteria. We will select articles that meet the following inclusion criteria: (a) include discussion or use of PROMs and/or PBOMs and/or PREMs for Long COVID health outcomes, (b) pertain to adults or children living with Long COVID and/or their caregivers, (c) are based in research or clinical settings, (d) are published from 2020 onwards and (e) are published in English or French languages (based on the capacity and knowledge of these languages among our research team). We will exclude review articles or conference abstracts but use these to hand search for other potentially relevant articles.</p><p>Once we reach agreement on the pilot screening process, three pairs of researchers will independently perform calibration training on 20 citation titles and abstracts (or until at least five citations are found to meet inclusion criteria). If inter-rater agreements are below 80%,<xref rid="R66" ref-type="bibr"><sup>66</sup></xref> we will clarify the eligibility criteria and repeat the calibration training. Then, six independent researchers will review all remaining citation titles and abstracts independently for assessment against the selection criteria. We will resolve any conflicts that arise via discussion. If unable to come to an agreement, a senior member of the research team will resolve the conflicts.</p><p>We will import the full text of potentially relevant sources into Covidence.<xref rid="R65" ref-type="bibr"><sup>65</sup></xref> Eight researchers will pilot screen the first five full text reviews. The same eight team members will then independently review all full texts against the selection criteria. We will resolve any conflicts that arise via discussion or, when necessary, with a senior member of the research team.</p></sec><sec id="s2-7"><title>Step 4: charting the data</title><p>We will extract the following data from included articles: (a) characteristics of the article: author(s), year of publication, article country of origin, purpose, study design, target population (adults living with Long COVID, children living with Long COVID, caregivers), demographics of participants (including but not limited to age and gender); (b) terminology and definition of Long COVID in the context of the article; (c) health outcome(s) (constructs) assessed and outcome measures used in the context of Long COVID; (d) characteristics of the outcome measures (type: PROM, PBOM, PREM; purpose: descriptive/discriminative, evaluative, predictive; number and type of domains; number of items; context of administration: research or clinical practice; administrator of the outcome measures: patient, clinician, researcher, caregiver; mode of administration: online with computer, tablet or phone or on paper, interviewer administered); (e) measurement properties for each outcome measure reported by included studies in the context of people living with Long COVID (if applicable: reliability, validity, responsiveness, interpretability) according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) taxonomy of measurement properties<xref rid="R67" ref-type="bibr"><sup>67</sup></xref>; and (f) implementation considerations for outcome measurement in the context of Long COVID from authors (if applicable). We will extract data using Microsoft Excel (<xref rid="SP6" ref-type="supplementary-material">online supplemental file 6</xref>: Data Extraction Characteristics and Variables &#8211; Operational Definitions).<xref rid="R68" ref-type="bibr"><sup>68</sup></xref> Four researchers will pilot the data extraction form by independently extracting data from five articles that meet the selection criteria and, if necessary, refine the form after piloting. The research team will also consult members of the broader team who have lived experiences and/or are clinicians to ensure data extracted will be relevant to advancing current understanding of outcome measurement among people living with Long COVID and their caregivers. We will document revisions to the data extraction form. Two members of the research team will independently extract data from all remaining full texts onto the finalised data extraction form using Microsoft Excel.<xref rid="R68" ref-type="bibr"><sup>68</sup></xref> A third researcher will mitigate discrepancies during data extraction.</p><p>For articles with the purpose of assessing measurement properties of outcome measures used among people living with Long COVID and their caregivers, we will extract data pertaining to their methodological quality using the COSMIN checklist for assessing the methodological quality of studies on measurement properties.<xref rid="R56" ref-type="bibr"><sup>56</sup></xref> While we understand that methodological quality assessment is not typically a component of scoping reviews,<xref rid="R69" ref-type="bibr"><sup>69</sup></xref> assessing the methodological quality of the subset of articles that assessed measurement properties will be important given that our aim with the framework is to provide guidance for measurement in the context of Long COVID. Two researchers will independently assess the methodological quality, and a third reviewer will discuss and resolve any disagreements.</p></sec><sec id="s2-8"><title>Step 5: collating, summarising and reporting results &#8211; creating a preliminary framework of measurement</title><p>We will describe the characteristics of included articles using frequencies (percentages) for dichotomous or categorical variables. For continuous variables, we will use means and SD when data are normally distributed and medians (IQRs) when data are not. We will conduct a descriptive content analysis of text data using an inductive approach to identify categories and summarise the extracted data.<xref rid="R70" ref-type="bibr"><sup>70</sup></xref> Specifically, we will describe the characteristics of outcome measures and associated measurement properties and implementation considerations (if applicable) in the context of Long COVID. These will be presented in summary tables or figures. We will map extracted data into a preliminary Framework of Measurement that includes: PROMs, PBOMs and PREMs to assess health outcomes for people living with Long COVID and their caregivers; the measurement properties of the outcome measures (and their methodological quality of assessment); and implementation considerations of the outcome measures. This framework will also highlight gaps in knowledge about measurement of health outcomes for people living with Long COVID and their caregivers. We will contextualise the framework as it relates to future recommendations and implications for outcome measurement in the context of Long COVID clinical practice and research.</p></sec><sec id="s2-9"><title>Step 6: consultation</title><p>There will be two phases to our consultation process. Concurrent to the scoping evidence review (steps 1&#8211;5), we will conduct an environmental scan involving administration of a cross-sectional web-based questionnaire to identify evidence in outcome measurement and relevant implementation considerations not captured in the evidence review (step 6 &#8211; phase 1). Upon development of a preliminary framework, we will conduct international focus group discussions with key consultants (after step 5) to review and refine the preliminary framework (step 6 &#8211; phase 2).</p><sec id="s2-9-1"><title>Consultation phase 1: environmental scan (concurrent with the scoping evidence review)</title><p>We will administer a cross-sectional web-based questionnaire to key consultants to supplement the findings from our evidence review by: (a) identifying the relevant grey literature (unpublished literature, trial registers, clinical guidelines, policy documents) on outcome measures used in the context of Long COVID not retrieved from the database search; (b) identifying the strengths, limitations and knowledge gaps of current outcome measures in the context of Long COVID; and (c) identifying considerations for outcome measurement (<xref rid="SP7" ref-type="supplementary-material">online supplemental file 7</xref>: Consultation 1 &#8211; Web-based Questionnaire).</p><sec id="s2-9-1-1"><title>Consultants</title><p>We will include key consultants internationally, with experience or expertise in outcome measurement for Long COVID. Specifically, we will include consultants who: (a) are &#8805;18 years old; (b) have experience using or completing outcome measures for adults or children living with Long COVID and their caregivers (for themselves or for someone they provide care for); and (c) are able to read and understand English. Consultants may include, but will not be limited to members of LCW<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> and the Rehabilitation Science Research Network for COVID,<xref rid="R71" ref-type="bibr"><sup>71</sup></xref> and may include people with lived experiences with Long COVID, caregivers of people living with Long COVID, clinicians, researchers, policy-makers, evaluators for health service organisations and representatives from community organisations. The Rehabilitation Science Research Network for COVID is comprised of over 100 members (people with lived experiences, clinicians and researchers) supporting and conducting research on Long COVID.<xref rid="R71" ref-type="bibr"><sup>71</sup></xref></p></sec><sec id="s2-9-1-2"><title>Sampling and recruitment</title><p>Recruitment of consultants will be led by a core team of researchers within MAP LC, many of whom represent Long COVID research networks (such as LCW and the Rehabilitation Science Research Network for COVID), community support groups for people living with Long COVID or are involved in other research teams with an interest in outcome measurement for Long COVID. We will establish a sampling frame of potential individuals who meet the inclusion criteria for our consultation and purposively recruit to obtain representation of multiple geographic regions, people living with Long COVID, clinicians and researchers. Members of our core team have access to these research teams and networks. Next, we will use snowball sampling to facilitate recruitment through peers of consultants in the study, including internationally.<xref rid="R70" ref-type="bibr"><sup>70</sup></xref> We will send an invitation email requesting voluntary participation to potential consultants from our sampling frame who meet the inclusion criteria and possess interest and expertise in Long COVID and measurement. We will use a modified Dillman approach,<xref rid="R72" ref-type="bibr"><sup>72</sup></xref> with reminder emails sent to potential consultants at 1&#8201;week and 2&#8201;weeks after the initial invitation email. Consultant characteristics will be collated weekly, and we will target recruitment efforts to maximise the diversity of consultants.</p></sec><sec id="s2-9-1-3"><title>Sample size estimation</title><p>We aim to recruit a maximum of 50 participants for the environmental scan (web-based questionnaire). Given the sizeable network of people with expertise and experiences in outcome measurement for Long COVID within our research team and among their individual networks, we anticipate that we will be able to obtain this sample size.</p></sec><sec id="s2-9-1-4"><title>Data collection: questionnaire</title><p>We will administer a web-based self-reported questionnaire in English using Qualtrics software.<xref rid="R73" ref-type="bibr"><sup>73</sup></xref> Potential consultants will be asked to self-identify their eligibility (experience using or completing outcome measures for Long COVID). The web-based questionnaire will include three main sections: section one: personal characteristics (including what group they represent), clinical experiences (if applicable) and research experiences (if applicable); section two: outcome measures used for adults and children living with Long COVID and their caregivers (and associated published or unpublished literature, trial registries, clinical guidelines or policy documents that reference those outcome measures); and section three: overall impressions of outcome measurement in Long COVID. Sections two and three include questions about preferences and perceived limitations of existing measures to assess health outcomes and implementation considerations for outcome measurement among adults and children living with Long COVID and their caregivers. At the end of the questionnaire, consultants will be asked if they are willing to be contacted for the future consultation phase of the study. Responses from Qualtrics will be exported to a Microsoft Excel worksheet and SPSS Statistics V.29.0.1.0 for analysis.<xref rid="R68" ref-type="bibr"><sup>68 74</sup></xref></p></sec><sec id="s2-9-1-5"><title>Analysis of environmental scan questionnaire data</title><p>We will analyse the questionnaire responses using frequencies (percentage) and medians (IQRs) for categorical and continuous variables, respectively, and descriptive content analysis of open-ended responses.<xref rid="R75" ref-type="bibr"><sup>75</sup></xref></p></sec><sec id="s2-9-1-6"><title>Bringing evidence review and environmental scan together: drafting the preliminary framework of measurement</title><p>Results from the evidence review and environmental scan will be considered in unison to draft a preliminary Framework of Measurement for Long COVID. The research team will meet to discuss the results of the evidence review and environmental scan and to establish key components of the Framework. A draft of the framework will be reviewed by the full research team for feedback prior to subsequent phases.</p></sec></sec></sec><sec id="s2-10"><title>Consultation phase 2: focus groups</title><p>We will conduct a cross-sectional international consultation using focus groups with key consultants to review and refine the preliminary Framework of Measurement. To increase accessibility and international and remote participation, we will conduct the focus group discussions online via Zoom,<xref rid="R76" ref-type="bibr"><sup>76</sup></xref> accounting for time zone differences. We will schedule breaks during the focus groups, web-camera use will be optional and we will circulate focus group materials, including the preliminary Framework of Measurement, prior to the scheduled discussion. Potential consultants will be able to contact the research coordinator to request other accessibility accommodations as needed.</p><sec id="s2-10-1"><title>Consultants</title><p>We will include key consultants internationally, with experience or expertise in outcome measurement for Long COVID. Inclusion criteria will be the same as for consultation phase 1, specifically adults (&#8805;18 years), with experience using or completing outcome measures for adults or children living with Long COVID and their caregivers and who are able to read and understand English.</p></sec><sec id="s2-10-2"><title>Sampling and recruitment</title><p>We will develop a sampling frame, drawing on the networks of MAP LC team members, word of mouth and those who expressed interest in future stages of research in phase 1 of our consultation. We will use a non-randomised, purposive and targeted sampling strategy to recruit key consultants from our sampling frame who represent different geographic regions, people with lived experiences, clinicians and researchers.<xref rid="R77" ref-type="bibr"><sup>77</sup></xref> We will email potential consultants from the sampling frame, asking them to participate in a focus group discussion with an attached letter of information and informed consent.</p></sec><sec id="s2-10-3"><title>Sample size estimation</title><p>We aim to recruit a maximum of 30 consultants for the online focus groups. We will conduct 5&#8211;6 online focus groups (via Zoom) with 3&#8211;5 consultants per group for a total sample of 15&#8211;30 consultants.<xref rid="R78" ref-type="bibr"><sup>78</sup></xref></p></sec><sec id="s2-10-4"><title>Data collection: focus group discussions</title><p>At the beginning of the focus group sessions, we will present the preliminary framework using a slide-deck presentation and then facilitate discussion by asking key consultants for feedback. Specifically, we will ask them to (a) review the components of the preliminary framework, (b) identify strengths and limitations of the outcome measures used in the context of Long COVID, (c) identify implementation considerations for use of existing outcome measures in the context of Long COVID and (d) highlight needs for future research. We will ask for suggestions on how to revise the framework. Finally, we will ask consultants for their guidance on strategies to translate the framework for broader uptake and usage among clinicians, researchers and people with lived experiences to guide the assessment, management and evaluation of Long COVID. One researcher will facilitate the discussions using a semistructured focus group discussion guide while another researcher will take notes of important topics and themes that arise during focus groups (<xref rid="SP8" ref-type="supplementary-material">online supplemental file 8</xref>: Focus Group Discussion Guide). We will audio record and transcribe the focus group discussions verbatim using Zoom software.</p></sec><sec id="s2-10-5"><title>Analysis: focus group transcripts</title><p>We will conduct a directed content analysis of the focus group transcripts informed by the aim of refining the Framework according to our study objectives.<xref rid="R75" ref-type="bibr"><sup>75</sup></xref> Each transcript will be coded by two independent reviewers based on the specific aims of the focus group consultation: (a) overall feedback on the preliminary framework; (b) strengths and limitations of the outcome measures; (c) needs of future research; and (d) implementation considerations for existing outcome measures. These codes will be used to refine and revise the framework accordingly.</p></sec><sec id="s2-10-6"><title>Outputs</title><p>Results will yield a Framework of Measurement that identifies outcome measures, their properties and considerations for measurement in the context of Long COVID. Results will highlight the strengths and limitations of existing outcome measures and identify areas for future research in Long COVID measurement. Results will map existing evidence and identify knowledge gaps, which is an important step in developing and selecting robust outcome measures for people living with Long COVID and their caregivers.</p></sec></sec><sec id="s2-11"><title>Strengths and potential limitations of our approach</title><p>Key strengths of this study are our use of established scoping review methodology,<xref rid="R52" ref-type="bibr"><sup>52 55 79</sup></xref> our broad selection criteria involving a range of terminologies, study designs and methodologies, iterative piloting of the inclusion and data extraction process and reporting the quality of studies analysing outcome measures used among people living with Long COVID and their caregivers. This work directly addresses research priorities in Long COVID and rehabilitation by advancing approaches for health assessment, evaluating impact of interventions and models of services delivery.<xref rid="R80" ref-type="bibr"><sup>80</sup></xref> This study involves a community-engaged approach, involving an international multidisciplinary team comprised of people with lived experiences of Long COVID, caregivers, clinicians and researchers with expertise in Long COVID and outcome measurement. Team members are affiliated with LCW,<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> PC-COS,<xref rid="R81" ref-type="bibr"><sup>81</sup></xref> the Rehabilitation Science Research Network for COVID,<xref rid="R71" ref-type="bibr"><sup>71</sup></xref> and other groups with experience in Long COVID and measurement-related research. This study has the potential to identify outcome measures currently in use, and to identify knowledge gaps that will provide direction for future research. Further, consultation with the target population will: (1) address gaps in the published literature by directing us towards grey and unpublished literature, (2) provide insights on the outcome measures&#8217; real-world implementation, (3) refine and improve the preliminary Framework of Measurement and (4) direct effective knowledge translation strategies.</p><p>Despite these strengths, we might face potential challenges. Despite our broad search strategy of multiple databases, we may miss relevant articles and grey literature. A multitude of terminologies and synonyms exists for Long COVID, and while we aim to include all possible definitions in our search strategy, it is possible that some will be missed. To mitigate these limitations, we will include all possible terminologies for Long COVID in our search strategy, iteratively expanding our search by extracting definitions from the literature search and environmental scan. Additionally, we will consult with an information specialist to develop our search strategy. By including articles only published in English and French, we will exclude literature pertaining to outcome measurement and Long COVID in other languages, that will exclude outcome measures used in the context of Long COVID in other languages and contexts. We aim to target a diverse, international and representative group of consultants in the environmental scan and focus groups. However, we anticipate challenges associated with obtaining sufficient response rates, equal representation across groups and coordination across global time zones. We will undertake efforts to enhance participation, such as offering multiple time and date options and offering to meet one-on-one with interested individuals who are unable to attend any of the scheduled focus groups. We will draw on our diverse team of researchers, clinicians and people with lived experiences and their broad networks to support our recruitment efforts. Our recruitment strategy is limited to our networks within the research team. This may limit our ability to more broadly identify people with lived experiences of Long COVID, caregivers, clinicians, researchers, policy-makers, evaluators for health service organisations and representatives from community organizations who meet the inclusion criteria and may possess further valuable insight to advancing considerations for outcome measurement in Long COVID. We will ensure diversity of the sample of consultation by drawing on the vast and diverse networks of members of the research team to obtain comprehensive and constructive information to inform framework refinement in the consultation phase.</p></sec><sec id="s2-12"><title>Knowledge translation plan</title><p>We will create and publish a Framework of Measurement comprised of core outcome measures, their measurement properties and implementation considerations for use in Long COVID research and practice. We will translate this framework into an online menu of outcome measures for people living with Long COVID and their caregivers that can be used by clinicians, researchers and people with lived experiences to guide the assessment, management and evaluation of Long COVID. This menu, with hyperlinks to the relevant outcome measures (when publicly available), will be openly accessible on LCW&#8217;s website<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> and updated periodically with a record of dates and new literature. A corresponding guidance document to facilitate the appropriate selection of outcome measures and awareness of their associated measurement properties among researchers, clinicians, patients and their caregivers will also be made available.</p><p>We will disseminate the framework through multiple networks and platforms such as the Post-COVID-19 Interdisciplinary Clinical Care Network;<xref rid="R82" ref-type="bibr"><sup>82 83</sup></xref> Realise Canada&#8217;s Episodic Disability Network;<xref rid="R84" ref-type="bibr"><sup>84</sup></xref> Long COVID community groups that include, but are not limited to, COVID Long-Haulers Support Group Canada, Long COVID Physio, Patient-Led Research Collaborative and Long COVID Support;<xref rid="R85" ref-type="bibr">85</xref><xref rid="R88" ref-type="bibr">88</xref> and the Rehabilitation Science Research Network for COVID website.<xref rid="R71" ref-type="bibr"><sup>71</sup></xref> To reach patient populations and caregivers, we will develop a toolkit that they can use to ask important questions of their providers, similar to the work done in rheumatology populations.<xref rid="R89" ref-type="bibr"><sup>89 90</sup></xref> We also plan to present our findings at conferences including the Canadian Symposium on Long COVID,<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> International Forum on COVID Rehabilitation Research and Canadian Critical Care Trials Group presentation series on Long COVID.</p></sec></sec><sec sec-type="supplementary-material" id="s3"><title>Supplementary material</title><supplementary-material id="SP1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 1</label><media xlink:href="bmjopen-15-9-s001.docx" id="d67e1532" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP2" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 2</label><media xlink:href="bmjopen-15-9-s002.docx" id="d67e1537" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP3" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 3</label><media xlink:href="bmjopen-15-9-s003.docx" id="d67e1542" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP4" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 4</label><media xlink:href="bmjopen-15-9-s004.docx" id="d67e1547" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP5" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 5</label><media xlink:href="bmjopen-15-9-s005.docx" id="d67e1552" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP6" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 6</label><media xlink:href="bmjopen-15-9-s006.docx" id="d67e1557" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP7" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 7</label><media xlink:href="bmjopen-15-9-s007.docx" id="d67e1562" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SP8" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1136/bmjopen-2024-094497</object-id><label>online supplemental file 8</label><media xlink:href="bmjopen-15-9-s008.docx" id="d67e1567" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>We thank Michelle Kho (School of Rehabilitation Science, McMaster University), Katie Merriman (Faculty Liaison &amp; Instruction Librarian, Gerstein Science Information Centre, University of Toronto) and Julia Nathanson (Department of Physical Therapy, Temerty Faculty of Medicine, University of Toronto) for their contributions to this protocol. We acknowledge collaborations from the following groups: COVID Long Haulers Support Group Canada, Long COVID Physio, Long COVID Support, Patient-Led Research Collaborative (PLRC), PossAbility: ME, Long COVID &amp; Work, Post-COVID Core Outcomes Set (PC-COS) Steering Committee, Post-COVID-19 Interdisciplinary Clinical Care Network (PCCN), Realize Canada and the Rehabilitation Science Research Network for COVID.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This study is funded by the Long COVID Web. The Long COVID Web is funded by the Canadian Institutes of Health Research (CIHR) &#8211; FRN 185352. KKO is supported by a Canada Research Chair in Episodic Disability and Rehabilitation. JWB is supported by a Canada Research Chair in the prevention and management of chronic pain. AC is supported by a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. TSEP is supported by a Michael Smith Health Research BC/Lotte &amp; John Hecht Memorial Foundation Scholar Award (#SCH-2022-2664).</p></fn><fn fn-type="other"><p>Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (<ext-link xlink:href="https://doi.org/10.1136/bmjopen-2024-094497" ext-link-type="uri">https://doi.org/10.1136/bmjopen-2024-094497</ext-link>).</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Not applicable.</p></fn><fn fn-type="other"><p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, conduct, reporting or dissemination plans of this research. Refer to the Methods section for further details.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Haupert</surname><given-names>SR</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review</article-title><source>J Infect Dis</source><year>2022</year><volume>226</volume><fpage>1593</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiac136</pub-id><pub-id pub-id-type="pmid">35429399</pub-id><pub-id pub-id-type="pmcid">PMC9047189</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perlis</surname><given-names>RH</given-names></name><name name-style="western"><surname>Santillana</surname><given-names>M</given-names></name><name name-style="western"><surname>Ognyanova</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Prevalence and Correlates of Long COVID Symptoms Among US Adults</article-title><source>JAMA Netw Open</source><year>2022</year><volume>5</volume><elocation-id>e2238804</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.38804</pub-id><pub-id pub-id-type="pmid">36301542</pub-id><pub-id pub-id-type="pmcid">PMC9614581</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>National Center for Health Statistics</collab></person-group><article-title>Long covid: household pulse survey: centers for disease control and prevention</article-title><year>2024</year><comment>Available</comment><ext-link xlink:href="https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm2025" ext-link-type="uri">https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm2025</ext-link></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Aly</surname><given-names>Z</given-names></name><name name-style="western"><surname>Davis</surname><given-names>H</given-names></name><name name-style="western"><surname>McCorkell</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Long COVID science, research and policy</article-title><source>Nat Med</source><year>2024</year><volume>30</volume><fpage>2148</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/s41591-024-03173-6</pub-id><pub-id pub-id-type="pmid">39122965</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Government of Canada</collab></person-group><article-title>COVID-19: longer-term symptoms among Canadian adults</article-title><year>2024</year><comment>Available</comment><ext-link xlink:href="https://health-infobase.canada.ca/covid-19/post-covid-condition/summer-2024-report.html" ext-link-type="uri">https://health-infobase.canada.ca/covid-19/post-covid-condition/summer-2024-report.html</ext-link><comment>Accessed</comment><date-in-citation>16-Sep-2024</date-in-citation></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Callard</surname><given-names>F</given-names></name><name name-style="western"><surname>Perego</surname><given-names>E</given-names></name></person-group><article-title>How and why patients made Long Covid</article-title><source>Soc Sci Med</source><year>2021</year><volume>268</volume><fpage>113426</fpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2020.113426</pub-id><pub-id pub-id-type="pmid">33199035</pub-id><pub-id pub-id-type="pmcid">PMC7539940</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soriano</surname><given-names>JB</given-names></name><name name-style="western"><surname>Murthy</surname><given-names>S</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>JC</given-names></name><etal>et al</etal></person-group><article-title>A clinical case definition of post-COVID-19 condition by a Delphi consensus</article-title><source>Lancet Infect Dis</source><year>2022</year><volume>22</volume><fpage>e102</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(21)00703-9</pub-id><pub-id pub-id-type="pmid">34951953</pub-id><pub-id pub-id-type="pmcid">PMC8691845</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="report"><person-group person-group-type="author"><collab>National Institute for Health Care Excellence</collab></person-group><article-title>COVID-19 rapid guideline: managing the long-term effects of COVID-19</article-title><year>2020</year><pub-id pub-id-type="pmid">33555768</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perego</surname><given-names>E</given-names></name></person-group><article-title>Observations on the US Working Definition for Long Covid as of May 2023</article-title><source>SocArXiv</source><year>2023</year></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ely</surname><given-names>EW</given-names></name><name name-style="western"><surname>Brown</surname><given-names>LM</given-names></name><name name-style="western"><surname>Fineberg</surname><given-names>HV</given-names></name></person-group><article-title>Long Covid Defined</article-title><source>N Engl J Med</source><year>2024</year><volume>391</volume><fpage>1746</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1056/NEJMsb2408466</pub-id><pub-id pub-id-type="pmid">39083764</pub-id><pub-id pub-id-type="pmcid">PMC11687645</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenhalgh</surname><given-names>T</given-names></name><name name-style="western"><surname>Knight</surname><given-names>M</given-names></name><name name-style="western"><surname>A&#8217;Court</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Management of post-acute covid-19 in primary care</article-title><source>BMJ</source><year>2020</year><volume>370</volume><elocation-id>m3026</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.m3026</pub-id><pub-id pub-id-type="pmid">32784198</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>E</given-names></name></person-group><article-title>Two New Analyses Add to Long COVID Understanding</article-title><source>JAMA</source><year>2023</year><volume>330</volume><fpage>905</fpage><pub-id pub-id-type="doi">10.1001/jama.2023.15449</pub-id><pub-id pub-id-type="pmid">37610793</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>AJ</given-names></name><etal>et al</etal></person-group><article-title>Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>3528</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-30836-0</pub-id><pub-id pub-id-type="pmid">35764621</pub-id><pub-id pub-id-type="pmcid">PMC9240035</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ahrnsbrak</surname><given-names>R</given-names></name><name name-style="western"><surname>Rekito</surname><given-names>A</given-names></name></person-group><article-title>Evidence Mounts That About 7% of US Adults Have Had Long COVID</article-title><source>JAMA</source><year>2024</year><volume>332</volume><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1001/jama.2024.11370</pub-id><pub-id pub-id-type="pmid">38848092</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenhalgh</surname><given-names>T</given-names></name><name name-style="western"><surname>Sivan</surname><given-names>M</given-names></name><name name-style="western"><surname>Perlowski</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Long COVID: a clinical update</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>707</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(24)01136-X</pub-id><pub-id pub-id-type="pmid">39096925</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahmati</surname><given-names>M</given-names></name><name name-style="western"><surname>Udeh</surname><given-names>R</given-names></name><name name-style="western"><surname>Kang</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of Symptoms 3 Years Post-SARS-CoV-2 Infection</article-title><source>J Med Virol</source><year>2025</year><volume>97</volume><elocation-id>e70429</elocation-id><pub-id pub-id-type="doi">10.1002/jmv.70429</pub-id><pub-id pub-id-type="pmid">40476637</pub-id><pub-id pub-id-type="pmcid">PMC12143191</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Brien</surname><given-names>KK</given-names></name><name name-style="western"><surname>Brown</surname><given-names>DA</given-names></name><name name-style="western"><surname>McDuff</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study</article-title><source>BMJ Glob Health</source><year>2023</year><volume>8</volume><elocation-id>e011276</elocation-id><pub-id pub-id-type="doi">10.1136/bmjgh-2022-011276</pub-id><pub-id pub-id-type="pmcid">PMC9979585</pub-id><pub-id pub-id-type="pmid">36863719</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Brien</surname><given-names>KK</given-names></name><name name-style="western"><surname>Brown</surname><given-names>DA</given-names></name><name name-style="western"><surname>McDuff</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative study</article-title><source>PLoS One</source><year>2025</year><volume>20</volume><elocation-id>e0305187</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0305187</pub-id><pub-id pub-id-type="pmid">40014600</pub-id><pub-id pub-id-type="pmcid">PMC11867324</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>HE</given-names></name><name name-style="western"><surname>Assaf</surname><given-names>GS</given-names></name><name name-style="western"><surname>McCorkell</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Characterizing long COVID in an international cohort: 7 months of symptoms and their impact</article-title><source>EClinicalMedicine</source><year>2021</year><volume>38</volume><elocation-id>101019</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2021.101019</pub-id><pub-id pub-id-type="pmid">34308300</pub-id><pub-id pub-id-type="pmcid">PMC8280690</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="report"><person-group person-group-type="author"><collab>National Academies of Sciences, Engineering, and Medicine</collab></person-group><article-title>A long covid definition: a chronic, systemic disease state with profound consequences</article-title><year>2024</year><pub-id pub-id-type="pmid">39110819</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Twomey</surname><given-names>R</given-names></name><name name-style="western"><surname>DeMars</surname><given-names>J</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study</article-title><source>Phys Ther</source><year>2022</year><volume>102</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1093/ptj/pzac005</pub-id><pub-id pub-id-type="pmcid">PMC9383197</pub-id><pub-id pub-id-type="pmid">35079817</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>TL</given-names></name><name name-style="western"><surname>Weitzer</surname><given-names>DJ</given-names></name></person-group><article-title>Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology</article-title><source>Medicina (Kaunas)</source><year>2021</year><volume>57</volume><elocation-id>418</elocation-id><pub-id pub-id-type="doi">10.3390/medicina57050418</pub-id><pub-id pub-id-type="pmid">33925784</pub-id><pub-id pub-id-type="pmcid">PMC8145228</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>L</given-names></name><name name-style="western"><surname>Valencia</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Garvert</surname><given-names>DW</given-names></name><etal>et al</etal></person-group><article-title>Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><elocation-id>e0197811</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0197811</pub-id><pub-id pub-id-type="pmid">29856774</pub-id><pub-id pub-id-type="pmcid">PMC5983853</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Rayner</surname><given-names>C</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>R</given-names></name></person-group><source>Long covid implications for the workplace</source><publisher-name>Oxford University Press UK</publisher-name><year>2021</year><fpage>121</fpage><lpage>3</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/occmed/kqab042</pub-id><pub-id pub-id-type="pmid">33822179</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kuang</surname><given-names>S</given-names></name><name name-style="western"><surname>Early</surname><given-names>S</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Experiences of canadians with long-term symptoms following covid-19</article-title><publisher-name>Statistics Canada</publisher-name><year>2023</year></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perlis</surname><given-names>RH</given-names></name><name name-style="western"><surname>Lunz Trujillo</surname><given-names>K</given-names></name><name name-style="western"><surname>Safarpour</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Association of Post-COVID-19 Condition Symptoms and Employment Status</article-title><source>JAMA Netw Open</source><year>2023</year><volume>6</volume><elocation-id>e2256152</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.56152</pub-id><pub-id pub-id-type="pmid">36790806</pub-id><pub-id pub-id-type="pmcid">PMC9932847</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerksieck</surname><given-names>P</given-names></name><name name-style="western"><surname>Ballouz</surname><given-names>T</given-names></name><name name-style="western"><surname>Haile</surname><given-names>SR</given-names></name><etal>et al</etal></person-group><article-title>Post COVID-19 condition, work ability and occupational changes in a population-based cohort</article-title><source>Lancet Reg Health Eur</source><year>2023</year><volume>31</volume><elocation-id>100671</elocation-id><pub-id pub-id-type="doi">10.1016/j.lanepe.2023.100671</pub-id><pub-id pub-id-type="pmid">37366496</pub-id><pub-id pub-id-type="pmcid">PMC10287546</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aghaei</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Impact of COVID-19 symptoms on social aspects of life among female long haulers: A qualitative study</article-title><source>Res Sq</source><year>2022</year><pub-id pub-id-type="doi">10.21203/rs.3.rs-1285284/v1</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aghaei</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Social Life of Females with Persistent COVID-19 Symptoms: A Qualitative Study</article-title><source>Int J Environ Res Public Health</source><year>2022</year><volume>19</volume><elocation-id>9076</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph19159076</pub-id><pub-id pub-id-type="pmid">35897448</pub-id><pub-id pub-id-type="pmcid">PMC9331983</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodman</surname><given-names>ML</given-names></name><name name-style="western"><surname>Molldrem</surname><given-names>S</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Long COVID and mental health correlates: a new chronic condition fits existing patterns</article-title><source>Health Psychol Behav Med</source><year>2023</year><volume>11</volume><elocation-id>2164498</elocation-id><pub-id pub-id-type="doi">10.1080/21642850.2022.2164498</pub-id><pub-id pub-id-type="pmid">36643576</pub-id><pub-id pub-id-type="pmcid">PMC9833408</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></name></person-group><article-title>Meaning and measurement of caregiver outcomes</article-title><source>Int Psychogeriatr</source><year>2007</year><volume>19</volume><fpage>363</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1017/S1041610207005182</pub-id><pub-id pub-id-type="pmid">17391571</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macpherson</surname><given-names>K</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>K</given-names></name><name name-style="western"><surname>Harbour</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><elocation-id>e050979</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2021-050979</pub-id><pub-id pub-id-type="pmcid">PMC8753091</pub-id><pub-id pub-id-type="pmid">35017239</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>GM</given-names></name><name name-style="western"><surname>Bach</surname><given-names>K</given-names></name><name name-style="western"><surname>Bobos</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Understanding How Post&#8211;COVID-19 Condition Affects Adults and Health Care Systems</article-title><source>JAMA Health Forum</source><year>2023</year><pub-id pub-id-type="doi">10.1001/jamahealthforum.2023.1933</pub-id><pub-id pub-id-type="pmid">37418268</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SE</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID</article-title><source><italic toggle="yes">Infect Chemother</italic></source><year>2022</year><volume>54</volume><fpage>566</fpage><pub-id pub-id-type="doi">10.3947/ic.2022.0141</pub-id><pub-id pub-id-type="pmid">36196612</pub-id><pub-id pub-id-type="pmcid">PMC9533168</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ware</surname><given-names>JE</given-names></name></person-group><source>Measuring functioning and well-being: the medical outcomes study approach</source><publisher-name>Duke University Press</publisher-name><year>1992</year></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erlandson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Geng</surname><given-names>LN</given-names></name><name name-style="western"><surname>Selvaggi</surname><given-names>CA</given-names></name><etal>et al</etal></person-group><article-title>Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort</article-title><source>Ann Intern Med</source><year>2024</year><volume>177</volume><fpage>1209</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.7326/M24-0737</pub-id><pub-id pub-id-type="pmid">39133923</pub-id><pub-id pub-id-type="pmcid">PMC11408082</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guyatt</surname><given-names>GH</given-names></name><name name-style="western"><surname>Kirshner</surname><given-names>B</given-names></name><name name-style="western"><surname>Jaeschke</surname><given-names>R</given-names></name></person-group><article-title>Measuring health status: what are the necessary measurement properties?</article-title><source>J Clin Epidemiol</source><year>1992</year><volume>45</volume><fpage>1341</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/0895-4356(92)90194-r</pub-id><pub-id pub-id-type="pmid">1460470</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirshner</surname><given-names>B</given-names></name><name name-style="western"><surname>Guyatt</surname><given-names>G</given-names></name></person-group><article-title>A methodological framework for assessing health indices</article-title><source>J Chronic Dis</source><year>1985</year><volume>38</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/0021-9681(85)90005-0</pub-id><pub-id pub-id-type="pmid">3972947</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinfurt</surname><given-names>KP</given-names></name><name name-style="western"><surname>Reeve</surname><given-names>BB</given-names></name></person-group><article-title>Patient-Reported Outcome Measures in Clinical Research</article-title><source>JAMA</source><year>2022</year><volume>328</volume><fpage>472</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1001/jama.2022.11238</pub-id><pub-id pub-id-type="pmid">35838745</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>E</given-names></name><name name-style="western"><surname>Burnell</surname><given-names>J</given-names></name><name name-style="western"><surname>Adams</surname><given-names>H</given-names></name><etal>et al</etal></person-group><source>Developing and implementing performance outcome assessments: evidentiary, methodologic, and operational considerations</source><publisher-name>Therapeutic Innovation &amp; Regulatory Science</publisher-name><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2168479018772569</pub-id><pub-id pub-id-type="pmcid">PMC6027603</pub-id><pub-id pub-id-type="pmid">29739255</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drummond</surname><given-names>M</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>B</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>TJ</given-names></name></person-group><article-title>Measuring the success of interventions for caregivers: a focussed systematic review</article-title><source>Curr Opin Support Palliat Care</source><year>2019</year><volume>13</volume><fpage>351</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/SPC.0000000000000461</pub-id><pub-id pub-id-type="pmid">31689272</pub-id><pub-id pub-id-type="pmcid">PMC6867664</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munblit</surname><given-names>D</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>T</given-names></name><name name-style="western"><surname>Akrami</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study</article-title><source>Lancet Respir Med</source><year>2022</year><volume>10</volume><fpage>715</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(22)00169-2</pub-id><pub-id pub-id-type="pmid">35714658</pub-id><pub-id pub-id-type="pmcid">PMC9197249</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munblit</surname><given-names>D</given-names></name><name name-style="western"><surname>Buonsenso</surname><given-names>D</given-names></name><name name-style="western"><surname>Sigfrid</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Post-COVID-19 condition in children: a COS is urgently needed</article-title><source>Lancet Respir Med</source><year>2022</year><volume>10</volume><fpage>628</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(22)00211-9</pub-id><pub-id pub-id-type="pmid">35714657</pub-id><pub-id pub-id-type="pmcid">PMC9197248</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seylanova</surname><given-names>N</given-names></name><name name-style="western"><surname>Chernyavskaya</surname><given-names>A</given-names></name><name name-style="western"><surname>Degtyareva</surname><given-names>N</given-names></name><etal>et al</etal></person-group><article-title>Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study &#8220;PC-COS Children&#8221;</article-title><source>Eur Respir J</source><year>2024</year><volume>63</volume><elocation-id>2301761</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.01761-2023</pub-id><pub-id pub-id-type="pmid">38359962</pub-id><pub-id pub-id-type="pmcid">PMC10938351</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorst</surname><given-names>SL</given-names></name><name name-style="western"><surname>Seylanova</surname><given-names>N</given-names></name><name name-style="western"><surname>Dodd</surname><given-names>SR</given-names></name><etal>et al</etal></person-group><article-title>Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study</article-title><source>Lancet Respir Med</source><year>2023</year><volume>11</volume><fpage>1101</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(23)00370-3</pub-id><pub-id pub-id-type="pmid">37926103</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davenport</surname><given-names>TE</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>SR</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Development and measurement properties of the PEM/PESE activity questionnaire (PAQ)</article-title><source>WOR</source><year>2023</year><volume>74</volume><fpage>1187</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.3233/WOR-220553</pub-id><pub-id pub-id-type="pmid">36938768</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sivan</surname><given-names>M</given-names></name><name name-style="western"><surname>Preston</surname><given-names>N</given-names></name><name name-style="western"><surname>Parkin</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome</article-title><source>J Med Virol</source><year>2022</year><volume>94</volume><fpage>4253</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1002/jmv.27878</pub-id><pub-id pub-id-type="pmid">35603810</pub-id><pub-id pub-id-type="pmcid">PMC9348420</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>SE</given-names></name><name name-style="western"><surname>Haroon</surname><given-names>S</given-names></name><name name-style="western"><surname>Subramanian</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis</article-title><source>BMJ</source><year>2022</year><volume>377</volume><elocation-id>e070230</elocation-id><pub-id pub-id-type="doi">10.1136/bmj-2022-070230</pub-id><pub-id pub-id-type="pmid">35477524</pub-id><pub-id pub-id-type="pmcid">PMC9043395</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Damant</surname><given-names>RW</given-names></name><name name-style="western"><surname>Rourke</surname><given-names>L</given-names></name><name name-style="western"><surname>Cui</surname><given-names>Y</given-names></name><etal>et al</etal></person-group><article-title>Reliability and validity of the post COVID-19 condition stigma questionnaire: A prospective cohort study</article-title><source>EClinicalMedicine</source><year>2023</year><volume>55</volume><elocation-id>101755</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2022.101755</pub-id><pub-id pub-id-type="pmid">36447641</pub-id><pub-id pub-id-type="pmcid">PMC9694932</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Machado</surname><given-names>FVC</given-names></name><name name-style="western"><surname>Meys</surname><given-names>R</given-names></name><name name-style="western"><surname>Delbressine</surname><given-names>JM</given-names></name><etal>et al</etal></person-group><article-title>Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19</article-title><source>Health Qual Life Outcomes</source><year>2021</year><volume>19</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/s12955-021-01691-2</pub-id><pub-id pub-id-type="pmid">33536042</pub-id><pub-id pub-id-type="pmcid">PMC7856622</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>C</given-names></name><name name-style="western"><surname>McInerney</surname><given-names>P</given-names></name><etal>et al</etal></person-group><article-title>Best practice guidance and reporting items for the development of scoping review protocols</article-title><source><italic toggle="yes">JBI Evid Synth</italic></source><year>2022</year><volume>20</volume><fpage>953</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.11124/JBIES-21-00242</pub-id><pub-id pub-id-type="pmid">35102103</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arksey</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Malley</surname><given-names>L</given-names></name></person-group><article-title>Scoping studies: towards a methodological framework</article-title><source>Int J Soc Res Methodol</source><year>2005</year><volume>8</volume><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1080/1364557032000119616</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name><name name-style="western"><surname>Shamseer</surname><given-names>L</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement</article-title><source>Syst Rev</source><year>2015</year><volume>4</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/2046-4053-4-1</pub-id><pub-id pub-id-type="pmid">25554246</pub-id><pub-id pub-id-type="pmcid">PMC4320440</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pozzar</surname><given-names>R</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Underhill-Blazey</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Threats of Bots and Other Bad Actors to Data Quality Following Research Participant Recruitment Through Social Media: Cross-Sectional Questionnaire</article-title><source>J Med Internet Res</source><year>2020</year><volume>22</volume><elocation-id>e23021</elocation-id><pub-id pub-id-type="doi">10.2196/23021</pub-id><pub-id pub-id-type="pmid">33026360</pub-id><pub-id pub-id-type="pmcid">PMC7578815</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>E</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>W</given-names></name><etal>et al</etal></person-group><article-title>PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation</article-title><source>Ann Intern Med</source><year>2018</year><volume>169</volume><fpage>467</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mokkink</surname><given-names>LB</given-names></name><name name-style="western"><surname>Terwee</surname><given-names>CB</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>DL</given-names></name><etal>et al</etal></person-group><article-title>The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study</article-title><source>Qual Life Res</source><year>2010</year><volume>19</volume><fpage>539</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1007/s11136-010-9606-8</pub-id><pub-id pub-id-type="pmid">20169472</pub-id><pub-id pub-id-type="pmcid">PMC2852520</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Long COVID Web</collab></person-group><year>2023</year><comment>Available</comment><ext-link xlink:href="https://www.longcovidweb.ca/" ext-link-type="uri">https://www.longcovidweb.ca/</ext-link></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perego</surname><given-names>E</given-names></name><name name-style="western"><surname>Callard</surname><given-names>F</given-names></name><name name-style="western"><surname>Stras</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Why the Patient-Made Term &#8220;Long Covid&#8221; is needed</article-title><source>Wellcome Open Res</source><year>2020</year><volume>5</volume><fpage>224</fpage><pub-id pub-id-type="doi">10.12688/wellcomeopenres.16307.1</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nalbandian</surname><given-names>A</given-names></name><name name-style="western"><surname>Sehgal</surname><given-names>K</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Post-acute COVID-19 syndrome</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><fpage>601</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01283-z</pub-id><pub-id pub-id-type="pmid">33753937</pub-id><pub-id pub-id-type="pmcid">PMC8893149</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michelen</surname><given-names>M</given-names></name><name name-style="western"><surname>Manoharan</surname><given-names>L</given-names></name><name name-style="western"><surname>Elkheir</surname><given-names>N</given-names></name><etal>et al</etal></person-group><article-title>Characterising long COVID: a living systematic review</article-title><source>BMJ Glob Health</source><year>2021</year><volume>6</volume><pub-id pub-id-type="doi">10.1136/bmjgh-2021-005427</pub-id><pub-id pub-id-type="pmcid">PMC8478580</pub-id><pub-id pub-id-type="pmid">34580069</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="other"><person-group person-group-type="author"><collab>National Health Service (NHS) England</collab></person-group><article-title>Commissioning guidance for post covid services for adults, children, and young people</article-title><year>2023</year></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>RA</given-names></name><name name-style="western"><surname>McAuley</surname><given-names>H</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>EM</given-names></name><etal>et al</etal></person-group><article-title>Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study</article-title><source>Lancet Respir Med</source><year>2021</year><volume>9</volume><fpage>1275</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(21)00383-0</pub-id><pub-id pub-id-type="pmid">34627560</pub-id><pub-id pub-id-type="pmcid">PMC8497028</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="report"><person-group person-group-type="author"><collab>Centres for Disease Control and Prevention</collab></person-group><article-title>Post-covid conditions: information for healthcare providers</article-title><year>2023</year></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Centres for Disease Control and Prevention</collab></person-group><article-title>Post-covid conditions: information for healthcare providers</article-title><year>2021</year><comment>Available</comment><ext-link xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html" ext-link-type="uri">https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</ext-link></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="book"><article-title>Covidence systematic review software [program]</article-title><publisher-loc>Melbourne, Australia</publisher-loc></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shea</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>BC</given-names></name><name name-style="western"><surname>Wells</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both</article-title><source>BMJ</source><year>2017</year><volume>358</volume><elocation-id>j4008</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.j4008</pub-id><pub-id pub-id-type="pmid">28935701</pub-id><pub-id pub-id-type="pmcid">PMC5833365</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>COSMIN</collab></person-group><article-title>COSMIN taxonomy of measurement properties</article-title><year>2023</year><comment>Available</comment><ext-link xlink:href="https://www.cosmin.nl/tools/cosmin-taxonomy-measurement-properties/" ext-link-type="uri">https://www.cosmin.nl/tools/cosmin-taxonomy-measurement-properties/</ext-link></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="book"><article-title>Microsoft excel [program]</article-title><publisher-name>Microsoft Corporation</publisher-name><year>2016</year></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>CM</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Guidance for conducting systematic scoping reviews</article-title><source>Int J Evid Based Healthc</source><year>2015</year><volume>13</volume><fpage>141</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1097/XEB.0000000000000050</pub-id><pub-id pub-id-type="pmid">26134548</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pollock</surname><given-names>D</given-names></name><name name-style="western"><surname>Peters</surname><given-names>MDJ</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Recommendations for the extraction, analysis, and presentation of results in scoping reviews</article-title><source><italic toggle="yes">JBI Evid Synth</italic></source><year>2023</year><volume>21</volume><fpage>520</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.11124/JBIES-22-00123</pub-id><pub-id pub-id-type="pmid">36081365</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Rehabilitation Science Research Network for COVID</collab></person-group><article-title>Rehabilitation science research network for covid Toronto: rehabilitation science research network for COVID</article-title><year>2023</year><comment>Available</comment><ext-link xlink:href="https://rehabcovidnetwork.med.utoronto.ca/" ext-link-type="uri">https://rehabcovidnetwork.med.utoronto.ca/</ext-link><comment>Accessed</comment><date-in-citation>18-Aug-2023</date-in-citation></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Dillman</surname><given-names>DA</given-names></name></person-group><source>Mail and internet surveys: the tailored design method--2007 update with New Internet, visual, and mixed-mode guide</source><publisher-name>John Wiley &amp; Sons</publisher-name><year>2011</year></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="book"><article-title>Qualtrics [program]</article-title><publisher-loc>Provo, Utah, USA</publisher-loc><year>2017</year></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="book"><article-title>SPSS statistics for windows, version 29.0.1.0 [program]</article-title><publisher-loc>Armonk, NY</publisher-loc><publisher-name>IBM Corp</publisher-name><year>2010</year></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kyng&#228;s</surname><given-names>H</given-names></name><name name-style="western"><surname>Mikkonen</surname><given-names>K</given-names></name><name name-style="western"><surname>K&#228;&#228;ri&#228;inen</surname><given-names>M</given-names></name></person-group><source>The application of content analysis in nursing science research</source><publisher-name>Springer</publisher-name><year>2019</year></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="report"><article-title>Zoom health care video communications [program]</article-title><year>2020</year></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyimbili</surname><given-names>F</given-names></name><name name-style="western"><surname>Nyimbili</surname><given-names>L</given-names></name></person-group><article-title>Types of Purposive Sampling Techniques with Their Examples and Application in Qualitative Research Studies</article-title><source><italic toggle="yes">BJMAS</italic></source><year>2024</year><volume>5</volume><fpage>90</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.37745/bjmas.2022.0419</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>V</given-names></name><name name-style="western"><surname>Braun</surname><given-names>V</given-names></name></person-group><part-title>Successful qualitative research: a practical guide for beginners</part-title><source>Successful qualitative research</source><year>2013</year><fpage>1</fpage><lpage>400</lpage></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levac</surname><given-names>D</given-names></name><name name-style="western"><surname>Colquhoun</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>KK</given-names></name></person-group><article-title>Scoping studies: advancing the methodology</article-title><source>Implement Sci</source><year>2010</year><volume>5</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-5-69</pub-id><pub-id pub-id-type="pmid">20854677</pub-id><pub-id pub-id-type="pmcid">PMC2954944</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Brien</surname><given-names>KK</given-names></name><name name-style="western"><surname>McDuff</surname><given-names>K</given-names></name><name name-style="western"><surname>Chattu</surname><given-names>VK</given-names></name><etal>et al</etal></person-group><article-title>A framework of research priorities in COVID rehabilitation from the Rehabilitation Science Research Network for COVID: an international consultation involving qualitative and quantitative research</article-title><source>Disabil Rehabil</source><year>2025</year><volume>47</volume><fpage>1754</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1080/09638288.2024.2382904</pub-id><pub-id pub-id-type="pmid">39049529</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Post-COVID Core Outcome Set (PC-COS)</collab></person-group><article-title>The Post-COVID Core Outcome Set (PC-COS) for children and young people: Post-COVID Core Outcome Set (PC-COS)</article-title><year>2022</year><comment>Available</comment><ext-link xlink:href="https://www.pc-cos.org/children" ext-link-type="uri">https://www.pc-cos.org/children</ext-link><comment>Accessed</comment><date-in-citation>23-Nov-2023</date-in-citation></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naik</surname><given-names>H</given-names></name><name name-style="western"><surname>Malbeuf</surname><given-names>M</given-names></name><name name-style="western"><surname>Shao</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>A Learning Health System for Long Covid Care and Research in British Columbia</article-title><source>NEJM Catalyst</source><year>2023</year><volume>4</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1056/CAT.23.0120</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>A</given-names></name><name name-style="western"><surname>Malbeuf</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoens</surname><given-names>AM</given-names></name><etal>et al</etal></person-group><article-title>Creating a provincial post COVID &#8208;19 interdisciplinary clinical care network as a learning health system during the pandemic: Integrating clinical care and research</article-title><source>Learning Health Systems</source><year>2023</year><volume>7</volume><pub-id pub-id-type="doi">10.1002/lrh2.10316</pub-id><pub-id pub-id-type="pmcid">PMC9348470</pub-id><pub-id pub-id-type="pmid">35942206</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Realize Canada</collab></person-group><year>2024</year><comment>Available</comment><ext-link xlink:href="https://www.realizecanada.org/" ext-link-type="uri">https://www.realizecanada.org/</ext-link></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="webpage"><article-title>COVID long haulers support group Canada (Goulding)</article-title><year>2021</year><comment>Available</comment><ext-link xlink:href="https://covidlonghaulcanada.com" ext-link-type="uri">https://covidlonghaulcanada.com</ext-link></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Long COVID Physio</collab></person-group><article-title>About long COVID Physio</article-title><comment>Available</comment><ext-link xlink:href="https://longcovid.physio/about" ext-link-type="uri">https://longcovid.physio/about</ext-link><comment>Accessed</comment><date-in-citation>10-May-2024</date-in-citation></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Patient-Led Research Collaborative</collab></person-group><year>2021</year><comment>Available</comment><ext-link xlink:href="https://patientresearchcovid19.com/" ext-link-type="uri">https://patientresearchcovid19.com/</ext-link></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Long COVID Support</collab></person-group><year>2021</year><comment>Available</comment><ext-link xlink:href="https://www.longcovid.org" ext-link-type="uri">https://www.longcovid.org</ext-link></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Global RA Network</collab></person-group><article-title>RA models of care pathway toolkit: global RA network</article-title><comment>n.d.</comment><comment>Available</comment><ext-link xlink:href="https://globalranetwork.org/project/ra-models-of-care-pathway-toolkit/2024" ext-link-type="uri">https://globalranetwork.org/project/ra-models-of-care-pathway-toolkit/2024</ext-link></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Arthritis Foundation</collab></person-group><article-title>Better living toolkit</article-title><year>2024</year><comment>Available</comment><ext-link xlink:href="https://www.arthritis.org/better-living-toolkit" ext-link-type="uri">https://www.arthritis.org/better-living-toolkit</ext-link></element-citation></ref></ref-list></back><sub-article id="sub-article1" article-type="aggregated-review-documents"><front-stub><title-group><article-title>Review Process File</article-title></title-group><pub-date pub-type="epub"><day>02</day><month>09</month><year>2025</year></pub-date></front-stub><body><fig id="d67e3489" position="anchor" orientation="portrait"><media xlink:href="bmjopen-2024-094497.reviewer_comments.pdf" position="float" orientation="portrait"/></fig></body></sub-article></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>